Barclays PLC boosted its stake in Proto Labs, Inc. (NYSE:PRLB – Free Report) by 66.4% during the 3rd quarter, HoldingsChannel reports. The fund owned 42,633 shares of the industrial products company’s ...
AbbVie (NYSE: ABBV) recently announced new results from two ongoing clinical trials evaluating epcoritamab, a CD3xCD20 bispecific T-cell-engaging antibody administered subcutaneously, in adult ...